With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the month's most ...

Amgen and Kyowa Kirin Provide Top-Line Results from Rocatinlimab Phase 3 IGNITE Study in Adults with Moderate to Severe Atopic Dermatitis The IGNITE study, which evaluated two dose strengths of ...

In dermatology, Amgen’s rocatinlimab and Sanofi’s amlitelimab, novel agents targeting the OX40/OX40L T-cell activation axis, are poised to address a critical upstream regulator of IL-4 and IL ...

A roundup of the most newsworthy healthcare press releases from PR Newswire, including Novo Nordisk's affordable semaglutide initiative and the fifth anniversary of COVID-19. NEW YORK, April 4 ...